0

Terameprocol

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP24150241
CAS24150-24-1
Structure
MDL NumberMFCD11113155
Molecular Weight358.47
InChI KeyORQFDHFZSMXRLM-IYBDPMFKSA-N
Description≥98% (HPLC)
SolubilityDMSO: ≥10 mg/mL
Assay≥98% (HPLC)
Colorwhite to off-white
Formpowder
Size10MG, 50MG
Storage Conditions−20°C
1

Nordihydroguaiaretic Acid Activates hTRPA1 and Modulates Behavioral Responses to Noxious Cold in Mice

William John Redmond, Maxime Camo, Vanessa Mitchell, Christopher Walter Vaughan, Mark Connor

Pharmacol Res Perspect. 2014 Dec;2(6):e00079.

PMID: 25505619

1

Phase I Study of Terameprocol in Patients With Recurrent High-Grade Glioma

Stuart A Grossman, Xiaobu Ye, David Peereboom, Myrna R Rosenfeld, Tom Mikkelsen, Jeffrey G Supko, Serena Desideri, Adult Brain Tumor Consortium

Neuro Oncol. 2012 Apr;14(4):511-7.

PMID: 22323663

1

Restraining the Flexibility of the Central Linker in Terameprocol Results in Constrained Analogs With Improved Growth Inhibitory Activity

Sherman Si Han Ho, Mei Lin Go

Bioorg Med Chem Lett. 2013 Nov 15;23(22):6127-33.

PMID: 24080463

1

Terameprocol (tetra-O-methyl Nordihydroguaiaretic Acid), an Inhibitor of Sp1-mediated Survivin Transcription, Induces Radiosensitization in Non-Small Cell Lung Carcinoma

Yunguang Sun, Nicholas J Giacalone, Bo Lu

J Thorac Oncol. 2011 Jan;6(1):8-14.

PMID: 21107289

1

The Anticancer Activity of the Transcription Inhibitor Terameprocol (meso-tetra-O-methyl Nordihydroguaiaretic Acid) Formulated for Systemic Administration

Rocio A Lopez, Amanda B Goodman, Melissa Rhodes, Jessica A L Blomberg, Jonathan Heller

Anticancer Drugs. 2007 Sep;18(8):933-9.

PMID: 17667599

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode